Cerebrolysin 5 ml 5 ampoules

Available at Pharmaegy Pharmacy. Use as directed by your doctor.

Cerebrolysin 5 ml Composition: Each 1 ml contains: Cerebrolysin concentrate (peptide complex) 215.2 mg Properties: Nootropic drug. Cerebrolysin contains low-molecular biologically active neuropeptides that penetrate the BBB and directly reach nerve cells. The drug has an organ-specific multimodal effect on the brain, i.e. provides metabolic regulation, neuroprotection, functional neuromodulation and neurotrophic activity. Metabolic regulation: Cerebrolysin increases the efficiency of aerobic energy metabolism of the brain, improves intracellular protein synthesis in the developing and aging brain. Neuroprotection: the drug protects neurons from the damaging effects of lactic acidosis, prevents the formation of free radicals, increases survival and prevents the death of neurons in hypoxia and ischemia, reduces the damaging neurotoxic effects of excitatory amino acids (glutamate). Neurotrophic activity: Cerebrolysin is the only nootropic peptidergic drug with proven neurotrophic activity similar to the action of natural neuronal growth factors (NGF), but manifested under conditions of peripheral administration. Functional neuromodulation: the drug has a positive effect on memory processes in cases of cognitive impairment. Indications: -Alzheimer's disease; -dementia syndrome of various origins; -chronic cerebrovascular insufficiency; -ischemic stroke; -traumatic injuries to the brain and spinal cord; -mental retardation in children; - Attention deficit disorders in children; - Endogenous depression resistant to antidepressants (as part of complex therapy). Method of administration and dosage: The drug is administered parenterally. The dosage and duration of administration depend on the nature and severity of the disease, as well as the patient's age. A single administration of the drug in a dose of up to 50 ml is possible, but a course of treatment is more preferable. The recommended course of treatment is daily injections for 10-20 days. Cerebrolysin® is administered parenterally in the form of intramuscular injections (up to 5 ml) and intravenous injections (up to 10 ml). The drug in a dose of 10 ml to 50 ml is recommended to be administered only by slow intravenous infusions after dilution with standard infusion solutions. The duration of infusions is from 15 to 60 minutes. Contraindications: - severe renal failure; - epileptic status; - hypersensitivity to the drug. Precautions: If injections are performed too quickly, a feeling of heat, sweating, and dizziness are possible. Therefore, the drug should be administered slowly. Clinical studies have shown that Cerebrolysin® does not affect the ability to drive vehicles and use mechanisms. Side effects: From the immune system: very rare - increased individual sensitivity, allergic reactions. Mental disorders: rare - the expected activation effect is accompanied by agitation, manifested by aggressive behavior, confusion, insomnia. From the nervous system: rare - too rapid administration of the drug can lead to dizziness; very rare - isolated cases of generalized epilepsy and one case of seizures were associated with Cerebrolysin. From the cardiovascular system: very rare - too rapid administration of the drug can lead to increased heart rate and arrhythmia. From the digestive system: very rare - dyspepsia, diarrhea, constipation, nausea, vomiting; rare - loss of appetite. From the skin and subcutaneous tissues: very rare - skin reactions; rare - with excessively rapid administration, a feeling of heat, sweating, itching is possible. General disorders and disorders at the injection site: very rare - redness, itching. Storage method: Store at a temperature not exceeding 25 degrees in a dark place. Packaging: The cardboard box contains 5 ampoules of 5 ml and paper instructions.